Antenatal Dexamethasone for Early Preterm Birth in Low-Resource Countries.
null nullOlufemi T OladapoJoshua P VogelGilda PiaggioMy-Huong NguyenFernando AlthabeA Metin GülmezogluRajiv BahlSuman P N RaoAyesha De CostaShuchita GuptaAbdullah H BaquiRasheda KhanamMohammod ShahidullahSaleha B ChowdhurySalahuddin AhmedNazma BegumArunangshu D RoyM A ShahedIffat A JabenFarida YasminM Mozibur RahmanAnjuman AraSoofia KhatoonGulshan AraShaheen AkterNasreen AkhterProbhat R DeyM Abdus SaburMohammad T AzadShahana F ChoudhuryM A MatinShivaprasad S GoudarSangappa M DhadedMrityunjay C MetgudYeshita V PujarManjunath S SomannavarSunil S VernekarVeena R HerekarShailaja R BidriSangamesh S MathapatiPreeti G PatilMallanagouda M PatilMuttappa R GudadinniHidaytullah R BijapureAshalata A MallapurGeetanjali M KatageriSumangala B ChikkamathBhuvaneshwari C YelamaliRamesh R PolSujata S MisraLeena DasSaumya NandaRashmita B NayakBipsa SinghZahida QureshiFredrick WereAlfred OsotiGeorge GwakoAhmed LavingJohn KinuthiaHafsa MohamedNawal AliyanAdelaide BarassaElizabeth KibaruMargaret MbugaLydia ThuraniraNjoroge J GithuaBernadine LuswetiAdejumoke I AyedeAdegoke G FaladeOlubukola A AdesinaAtinuke M AgunloyeOluwatosin O IyiolaWilfred SanniIfeyinwa K EjinkeonyeHadiza A IdrisChinyere V OkoliTheresa A IrinyenikanOmolayo A OlubosedeOlaseinde BelloOlufemi M OmololuOlanike A OlutekunbiAdesina L AkintanOlorunfemi O OwaRosena O OluwafemiIreti P EniowoAdetokunbo O FabamwoElizabeth A DisuJoy O AgbaraEbunoluwa A AdejuyigbeOluwafemi KutiHenry C AnyaboluIbraheem O AwowoleAkintunde O FehintolaBankole P KutiAnthony D IsahEyinade K OlatejuOlusanya AbiodunOlabisi F DedekeFrancis B AkinkunmiLawal OyeneyinOmotayo AdesiyunHadijat O RajiAdedapo B A AndeIkechukwu OkonkwoShabina AriffSajid B SoofiLumaan SheikhSaima ZulfiqarSadia OmerRaheel SikandarSalma SheikhDaniel GiordanoHugo GamerroGuillermo CarroliJose CarvalhoJames NeilsonElizabeth MolyneuxKhalid YunisKidza MugerwaHarish K ChellaniPublished in: The New England journal of medicine (2020)
Among women in low-resource countries who were at risk for early preterm birth, the use of dexamethasone resulted in significantly lower risks of neonatal death alone and stillbirth or neonatal death than the use of placebo, without an increase in the incidence of possible maternal bacterial infection. (Funded by the Bill and Melinda Gates Foundation and the World Health Organization; Australian and New Zealand Clinical Trials Registry number, ACTRN12617000476336; Clinical Trials Registry-India number, CTRI/2017/04/008326.).